01 2Lumakras/Lumykras
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 90
2020 Revenue in Millions : 0
Growth (%) : New Launch in 2021
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 285
2021 Revenue in Millions : 90
Growth (%) : 217
LOOKING FOR A SUPPLIER?